Dermatitis, Eczematous Completed Phase 2 Trials for Mapracorat (DB12041)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01359787Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)Treatment
NCT01407510HPA Axis Study in Japanese AdultsTreatment
NCT01408511HPA Axis Study in AdultsTreatment